Literature DB >> 21327628

Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital.

L Fallico1, C Boldrin, A Grossato, E Franchin, E De Canale, T Tommasini, S G Parisi, R Manganelli, G Palù.   

Abstract

BACKGROUND: Outbreaks of vancomycin-resistant Enterococcus faecium (VRE) strains is an emerging problem worldwide. Even if still relatively uncommon in European hospitals, infections caused by VRE have also been increasing recently in this continent.
METHODS: In this study, we characterized 50 consecutive VRE and 23 vancomycin-sensitive E. faecium (VSE) isolates collected in an Italian hospital. The presence of the esp gene and that of genes encoding resistance to glycopeptides was investigated by polymerase chain reaction (PCR). All of the isolates were typed by multi-locus sequence typing (MLST), and a selection of them also by pulsed-field gel electrophoresis (PFGE).
RESULTS: We found that all of the VRE and 18 (78%) of the VSE strains belonged to the single clonal complex-17 (CC17). The most represented sequence type (ST) was ST78 (34% of the isolates). When further analyzed by PFGE, ST78 isolates were subdivided into five pulsotypes, four of them closely related. The strong association between the esp gene and CC17 was confirmed. Interestingly, such an association was higher among vancomycin-resistant isolates. Most of the esp-positive isolates (34/46, 74%) encoded Esp4, a rare variant of this protein characterized by the absence of A repeats.
CONCLUSIONS: Our findings underscore the role of the CC17 lineage in the nosocomial spread of VRE and VSE, and its rapid local evolution, underscoring the need for programs designed to provide early detection in order to prevent its spreading among the nosocomial population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327628     DOI: 10.1007/s15010-011-0086-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis.

Authors:  Nathan Shankar; Arto S Baghdayan; Michael S Gilmore
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

2.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Molecular characterization of vancomycin-resistant Enterococcus faecium isolates from Korea.

Authors:  Kwan Soo Ko; Jin Yang Baek; Ji-Young Lee; Won Sup Oh; Kyong Ran Peck; Namyong Lee; Wee Gyo Lee; Kyungwon Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  The N-terminal domain of enterococcal surface protein, Esp, is sufficient for Esp-mediated biofilm enhancement in Enterococcus faecalis.

Authors:  Preeti M Tendolkar; Arto S Baghdayan; Nathan Shankar
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

8.  Vancomycin-resistant Enterococcus faecium isolates causing hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 lineage.

Authors:  Maria Grazia Bonora; Marco Ligozzi; Maria De Fatima; Luciana Bragagnolo; Antonio Goglio; Gian Carlo Guazzotti; Roberta Fontana
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

9.  A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity.

Authors:  Helen Leavis; Janetta Top; Nathan Shankar; Katrine Borgen; Marc Bonten; Jan van Embden; Rob J L Willems
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

10.  Epidemic and nonepidemic multidrug-resistant Enterococcus faecium.

Authors:  Helen L Leavis; Rob J L Willems; Janetta Top; Emile Spalburg; Ellen M Mascini; Ad C Fluit; Andy Hoepelman; Albert J de Neeling; Marc J M Bonten
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

View more
  4 in total

1.  Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.

Authors:  A Matsushima; S Takakura; M Yamamoto; Y Matsumura; M Shirano; M Nagao; Y Ito; Y Iinuma; T Shimizu; N Fujita; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-04       Impact factor: 3.267

2.  National surveillance on vancomycin-resistant Enterococcus faecium in Taiwan: emergence and widespread of ST414 and a Tn1546-like element with simultaneous insertion of IS1251-like and IS1678.

Authors:  An-Jing Kuo; Lin-Hui Su; Jwu-Ching Shu; Jann-Tay Wang; Jen-Hsien Wang; Chang-Phone Fung; Ju-Hsin Chia; Jang-Jih Lu; Tsu-Lan Wu
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

3.  Colonization Rate and Risk Factors of Vancomycin-Resistant Enterococci among Patients Received Hematopoietic Stem Cell Transplantation in Shiraz, Southern Iran.

Authors:  M Kaveh; A Bazargani; M Ramzi; H Sedigh Ebrahim-Saraie; H Heidari
Journal:  Int J Organ Transplant Med       Date:  2016-11-01

Review 4.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.